Threshold Pharmaceuticals, Inc. (THLD):企業の財務及び戦略的SWOT分析

GlobalDataが発行した調査報告書(GDPH82164FSA)
◆英語タイトル:Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82164FSA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年1月9日
◆ページ数:25
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary

Threshold Pharmaceuticals, Inc. (Threshold) is a biotechnology company that discovers and develops tumor-targeted therapies to treat cancer. The company products include evofosfamide, TH-4000 and [18F]-HX4. Its evofosfamide and TH-4000 are under evaluation for the treatment of a variety of tumor types. Threshold’s [18F]-HX4 is an in-licensed positron emission tomography (PET) imaging agent for hypoxia. The company’s clinical pipeline includes TH-CR-406, MAESTRO, TH-CR-413, TH-CR-408, TH-IST-4003, TH-IST-4004, TH-CR-410, TH-CR-407 and TH-IST-4001. Its clinical trials are used in the treatment of diseases such as soft tissue sarcoma, pancreatic cancer, non-squamous non-small cell lung cancer, advanced melanoma, multiple myeloma and advanced solid tumors. Threshold is headquartered in South San Francisco, California, the US.

Threshold Pharmaceuticals, Inc. Key Recent Developments

Nov 02, 2015: Threshold Pharmaceuticals Reports Third Quarter 2015 Financial and Operational Results
Sep 08, 2015: Threshold Pharmaceuticals Appoints Mark Hopkins, J.D., Ph.D., Vice President of Intellectual Property and Assistant General Counsel
Jul 30, 2015: Threshold Pharmaceuticals Reports Second Quarter 2015 Financial and Operational Results
Apr 30, 2015: Threshold Pharmaceuticals Reports First Quarter 2015 Financial and Operational Results
Mar 03, 2015: Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial and Operational Results

This comprehensive SWOT profile of Threshold Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Threshold Pharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Threshold Pharmaceuticals, Inc. – Key Information
Threshold Pharmaceuticals, Inc. – Overview
Threshold Pharmaceuticals, Inc. – Key Employees
Threshold Pharmaceuticals, Inc. – Key Employee Biographies
Threshold Pharmaceuticals, Inc. – Key Operational Heads
Threshold Pharmaceuticals, Inc. – Major Products and Services
Threshold Pharmaceuticals, Inc. – History
Threshold Pharmaceuticals, Inc. – Company Statement
Threshold Pharmaceuticals, Inc. – Locations And Subsidiaries
Threshold Pharmaceuticals, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Threshold Pharmaceuticals, Inc. – Business Description
Threshold Pharmaceuticals, Inc. – Corporate Strategy
Threshold Pharmaceuticals, Inc. – SWOT Analysis
SWOT Analysis – Overview
Threshold Pharmaceuticals, Inc. – Strengths
Threshold Pharmaceuticals, Inc. – Weaknesses
Threshold Pharmaceuticals, Inc. – Opportunities
Threshold Pharmaceuticals, Inc. – Threats
Threshold Pharmaceuticals, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Threshold Pharmaceuticals, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Threshold Pharmaceuticals, Inc., Key Information
Threshold Pharmaceuticals, Inc., Key Ratios
Threshold Pharmaceuticals, Inc., Share Data
Threshold Pharmaceuticals, Inc., Major Products and Services
Threshold Pharmaceuticals, Inc., History
Threshold Pharmaceuticals, Inc., Key Employees
Threshold Pharmaceuticals, Inc., Key Employee Biographies
Threshold Pharmaceuticals, Inc., Key Operational Heads
Threshold Pharmaceuticals, Inc., Other Locations
Threshold Pharmaceuticals, Inc., Subsidiaries
Threshold Pharmaceuticals, Inc., Key Manufacturing facilities
Threshold Pharmaceuticals, Inc., Key Competitors
Threshold Pharmaceuticals, Inc., SWOT Analysis
Threshold Pharmaceuticals, Inc., Ratios based on current share price
Threshold Pharmaceuticals, Inc., Annual Ratios
Threshold Pharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Threshold Pharmaceuticals, Inc., Performance Chart
Threshold Pharmaceuticals, Inc., Ratio Charts

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Threshold Pharmaceuticals, Inc. (THLD):企業の財務及び戦略的SWOT分析(Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆